Disseminated intravascular coagulation;Diffuse intravasale stolling

Nederlands Tijdschrift voor Geneeskunde

Volumn 144, Issue 10, 2000, Pages 470-475

  Levi, M ^a   De Jonge, E ^a   Ten Cate, H ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING INHIBITOR;

DISSEMINATED INTRAVASCULAR CLOTTING; FIBRIN DEPOSITION; FIBRINOLYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOPHYSIOLOGY; REVIEW; THROMBIN TIME;

ANTICOAGULANTS; ANTIFIBRINOLYTIC AGENTS; ARTERIOLES; BIOPSY; DISSEMINATED INTRAVASCULAR COAGULATION; FIBRINOLYSIS; HUMANS; KIDNEY; PLASMAPHERESIS; PLATELET TRANSFUSION;

EID: 0034603430     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Levi M, Cate H ten. Disseminated intravascular coagulation. N Engl J Med 1999;341:586-92.
2. Marder VJ, Feinstein D, Francis C, Colman RW. Consumptive thrombohemorrhagic disorders. In: Hirsh J, Marder VJ, Salzman EW, Colman RW, editors. Hemostasis and thrombosis. Basic principles and clinical practice. Philadelphia: Lippincott; 1994. p. 1023-63.
3. Thijs LG, Boer JP de, Groot MC de, Hack CE. Coagulation disorders in septic shock. Intensive Care Med 1993;19 Suppl 1:S8-15.
4. Bone RC. Gram-positive organisms and sepsis. Arch Intern Med 1994;154:26-34.
5. Gando S, Kameue T, Nanzaki S, Nakanishi Y. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost 1996;75:224-8.
6. Roumen RM, Hendriks T, Ven-Jongekrijg J van der, Nieuwenhuijzen GA, Sauerwein RW, Meer JW van der, et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 1993;218: 769-76.
7. Colman RW, Rubin RN. Disseminated intravascular coagulation due to malignancy. Semin Oncol 1990;17:172-86.
8. Avvisati G, Cate JW ten, Buller HR, Mandelli F. Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia. Lancet 1989;11:122-4.
9. Weiner CP. The obstetric patient and disseminated intravascular coagulation. Clin Perinatol 1986;13:705-17.
10. Sibai BM, Spinnato JA, Watson DL, Hill GA, Anderson GD. Pregnancy outcome in 303 cases with severe preeclampsia. Obstet Gynecol 1984;64:319-25.
11. Szlachetka DM. Kasabach-Merritt syndrome: a case review. Neonatal Netw 1998;17:7-15.
12. Aboulafia DM, Aboulafia ED. Aortic aneurysm-induced disseminated intravascular coagulation. Ann Vasc Surg 1996;10:396-405.
13. Ruggenenti P, Lutz J, Remuzzi G. Pathogenesis and treatment of thrombotic microangiopathy. Kidney Int 1997;58 Suppl:S97-101.
14. Creasey AA, Chang AC, Feigen L, Wun TC, Taylor jr FBJ, Hinshaw LB. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 1993;91:2850-6.
15. Levi M, Poll T van der, Cate H ten, Deventer SJH van. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur J Clin Invest 1997; 27:3-9.
16. Levi M, Cate H ten, Bauer KA, Poll T van der, Edgington TS, Büller HR, et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 1994;93:114-20.
17. Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992;101:816-23.
18. Conway EM, Rosenberg RD. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Biol 1988;8:5588-92.
19. Gando S, Nakanishi Y, Tedo I. Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome. Crit Care Med 1995;23:1835-42.
20. Mesters RM, Mannucci PM, Coppola R, Keller T, Ostermann H, Kienast J. Factor Vila and antithrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood 1996;88:881-6.
21. Bick RL, Baker WF. Diagnostic efficacy of the D-dimer assay in disseminated intravascular coagulation (DIC). Thromb Res 1992;65: 785-90.
22. Feinstein DI. Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy. Blood 1982;60:284-7.
23. Corrigan jr JJ. Heparin therapy in bacterial septicemia. J Pediatr 1977;91:695-700.
24. Eisele B, Lamy M, Thijs LG, Keinecke HO, Schuster HP, Matthias FR, et al. Antithrombin III in patients with severe sepsis. A randomized, placebocontrolled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis. Intensive Care Med 1998;24:663-72.
25. Levi M, Cate H ten, Poll T van der. Disseminated intravascular coagulation: state of the art. Thromb Haemost 1999;82:695-705.